Neuromodulation Market Worth CAGR of 11.8% by 2027

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on pocket
Pocket
Share on whatsapp
WhatsApp
Neuromodulation Market Worth CAGR of 11.8% by 2027

In February 2022, Medtronic (Ireland) received FDA approval for its InterStim X System, a next-generation personalized sacral nerve stimulation therapy for bladder and bowel control.Northbrook, IL 60062 — (SBWIRE) — 11/24/2022 — Neuromodulation Market is projected to reach USD 10.4 billion by 2027 from USD 6.0 billion in 2022…
Read More

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on pocket
Pocket
Share on whatsapp
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about new articles